Viswanathan, P C <br/><br/>
Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.  [electronic resource] 

 -  Circulation  Sep 2001 
 - 1200-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/hc3501.093797  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Arrhythmia Agents--pharmacology<br/>Arrhythmias, Cardiac--genetics<br/>Cell Line<br/>Electrocardiography--drug effects<br/>Flecainide--pharmacology<br/>Green Fluorescent Proteins<br/>Humans<br/>Ion Channel Gating--physiology<br/>Long QT Syndrome--genetics<br/>Luminescent Proteins--genetics<br/>Membrane Potentials--drug effects<br/>Mutation<br/>NAV1.5 Voltage-Gated Sodium Channel<br/>Patch-Clamp Techniques<br/>Recombinant Fusion Proteins--genetics<br/>Sodium Channels--genetics<br/>Syndrome<br/>Transfection